Advertise
NEWSLETTER
Allergan Aesthetics highlig...
Insilico, Tenacia expand AI...
New AI research reshapes ne...
Scalable biotech manufactur...
Cellbricks Therapeutics sec...
Allergan Aesthetics highlig...
Insilico, Tenacia expand AI...
New AI research reshapes ne...
Scalable biotech manufactur...
Cellbricks Therapeutics sec...
Cellular
Mitrix mitochondria

“Whole-body mitochondrial transfusion” start-up lands funding

Longevity companies to watch in 2021

NasDaq

Biotech Longeveron files for $30M IPO

Florida-based Longeveron files for a $30 million IPO, targeting aging-related conditions. Longeveron, a Phase 2 biotech

A year in Longevity: different perspectives

Rejuvenation Roadmap charts life extension progress

All the way from regenerative research to commercialisation

Longevity investment: Apollo aims for the moon

CohBar CEO on the development of a “true portfolio” of mitochondria based therapeutics for the treatment of chronic and age-related diseases.

It’s time to sit up and take notice of mitochondria

Spineless mouse

New Buck Institute study is treasure trove for longevity research

Cellvie

Harvard spin-off Cellvie Inc closes $5M seed round

Making the Longevity grade: expanded list of 1000 leading names

Mayo Clinic

Clearance of senescent cells for improved cognition

Oisin

Promising restorative therapy potentially 5 years away

Longevity Escape Velocity within 10 years?

Stanford study finds that blocking certain interactions on immune cells reverses age-related mental decline in older mice. Photography by Steve Fisch

“Adjust the immune system… de-age the brain”

Predicting longevity using polygenic risk scores

CohBar and NIAID announce that they are set to assess CB5064 Analogues for COVID-19 and respiratory distress treatment.

CohBar announces preclinical collaboration with NIAID

Kevin Perrott, co-founder of SENS and Oisin Biotechnologies, is now CEO of OpenCures focussing on developing interventions in age-related disease

Longevity and the art of motorcycle maintenance

Protein turnover decreases with age to preserve metabolic costs, especially in longer lived organisms including humans.

Protein turnover is correlated to lifespan

Longevity supplement Mitocholine addresses “brain energy gap” to counteract development of metabolic syndrome and impede onset of dementia.

New Longevity supplement targets cognitive decline

Research from the Buck Institute provides insights into how the immune system functions and opens up possibilities for immunotherapeutics.

New Buck Institute research is big news for Longevity

Turn Bio announce worldwide IP for mRNA tech

Using optogenetics on gut microbes can promote Longevity.

Gut health shines a light on Longevity

A year in Longevity: progress perspectives

Joined-up thinking and the hallmarks of aging

A new study by the Technion-Israel Institute of Technology identifies proteostasis decline as a hallmark of human cellular aging.

Proteostasis as a therapeutic target in age-related neurodegeneration

New preliminary study demonstrates spermidine maintains autophagy in T cells and may improve vaccine protection in older adults.

Autophagy in T cells maintained by spermidine

Switching off a newly-identified enzyme could reverse senescence, spotlighting a potential therapy avenue say the KAIST team.

Simulations open the door to cell aging reversal

Resetting cells to a youthful regenerative state

64x Bio will use proprietary platform to spearhead cell and gene therapy manufacture and to treat age-related diseases.

Viral vector start-up aims to tackle gene therapy Longevity bottleneck

We caught up with Bailey to find out the latest developments at Juvenescence, currently in the process of raising $100 – $150 million in new capital

Juvenescence CEO on near-term longevity breakthroughs

Longevity 2020: shaping-up nicely

Found: the missing link in the Longevity ‘supply-chain’

Cellular stochasticity and epigenetic drift in aging can provide Longevity targets and also provide insights into the origins of cancer.

A novel approach to aging – epigenetics and cellular variability

Some good news: announcing Longevity2020

Oxidants can slow cell aging

Protein coding gene linked to protective novel pathway in Alzheimer’s disease say a team of researchers in Finland.

Novel pathway to cracking the Alzheimer’s puzzle

Reason

The Reason behind Longevity: start-up opportunities

There's no place like plasma proteomics when it comes to understanding biological processes and discovering biomarkers says Dr Nir Barzilai

Profiling and understanding plasma proteomes could unlock Longevity

National Cancer Institute / Unsplash

Peptide molecule causes cancer cells to self destruct

Epigenetic regulation of protein homeostasis following DNA damage

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form